Legend Biotech Corp financial data

Symbol
LEGN on Nasdaq
Location
Somerset, NJ
Fiscal year end
31 December
Latest financial report
6-K - Q1 2024 - 13 May 2024

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $100,964,000 USD 19%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $1,735,825,000 USD -5.6%
Liabilities $619,718,000 USD 24%